Welcome to ACC’s Imaging Member Section!
Ron Blankstein, MD, FACC
Chair
@RonBlankstein
The mission of ACC's Imaging Member Section is to provide members who have a specific clinical or professional interest in imaging with a forum in which they can advance their professional priorities, offer input into the coordination of imaging activities within the College and facilitate networking with peers in their field.
The Leadership Council will represent those interests within the ACC and facilitate achieving consensus on issues affecting the various cardiology imaging modalities. The purpose of the Leadership Council will be to represent the interests of the cardiology imaging community and to work with ACC leadership to promote communication and cooperation among organizations and cardiovascular societies in the field.
The Section represents five major modalities within the cardiovascular imaging community: CT, MR, echocardiography, nuclear medicine and angiography. Section leaders recognize the importance of a multimodality perspective in diagnosis and facilitate their integration into research, education, quality, guidelines and more.
Questions? Contact ACC Member Care.
Section Announcements
March 17, 2026
Don’t miss Cardiovascular (CV) Imaging Section events at ACC.26! Check out the ACC.26 CV Imaging Section Events Guide to get a curated list of can’t-miss sessions and events. For a full list of all CV Imaging sessions, go to the online program planner.
February 27, 2026
Network with fellow ACC Imaging Section members and discuss the latest updates and initiatives within the field at the Imaging Section Meet-Up. Join your colleagues on Saturday, March 28 from 2:30-3:30 p.m. CT in the Lounge & Learn Pavilion, Meet Up Zone 2. Register here.
Not yet registered for ACC.26? Register here and plan your program.
February 9, 2026
A new JACC Focus Issue on Valve Disease “brings together pivotal trials, state-of-the-art reviews and expert guidance that reflect the field's rapid evolution, from earlier intervention to more refined device selection and longitudinal care,” writes JACC Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC. Read insights from the EARLY-TAVR trial, one-year outcomes from the LANDMARK trial in severe aortic stenosis, a comprehensive state-of-the-art review on aortic regurgitation, the 2025 ACC Expert Consensus Decision Pathway on tricuspid regurgitation and more. Read the full issue.
Log in to MyACC
